Amrize (NYSE:AMRZ) Given Hold (C-) Rating at Weiss Ratings

Key Points

• Amrize's stock has been given a "hold (C-)" rating by Weiss Ratings, with a consensus price target of $58.25.
• Analysts have mixed views, with Royal Bank of Canada and Oppenheimer issuing buy ratings, while Zacks Research downgraded the stock to a "strong sell".
• Insider transactions included significant purchases by CFO Ian A. Johnston and Jaime Hill, indicating confidence in the company's future performance.

Amrize (NYSE:AMRZ - Get Free Report)'s stock had its "hold (c-)" rating reiterated by analysts at Weiss Ratings in a research note issued on Wednesday,Weiss Ratings reports.

Other analysts have also issued reports about the stock. Royal Bank Of Canada reduced their price target on shares of Amrize from $61.00 to $54.00 and set an "outperform" rating for the company in a research note on Friday, August 8th. Zacks Research lowered shares of Amrize from a "hold" rating to a "strong sell" rating in a research note on Wednesday, August 27th. Oppenheimer assumed coverage on Amrize in a research note on Tuesday, September 9th. They issued an "outperform" rating and a $62.00 price target on the stock. Wells Fargo & Company assumed coverage on Amrize in a research report on Tuesday. They set an "overweight" rating and a $57.00 price objective for the company. Finally, JPMorgan Chase & Co. raised their target price on Amrize from $52.00 to $60.00 and gave the stock an "overweight" rating in a research report on Tuesday, August 26th. Four research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $58.25.

Amrize Stock Performance

Shares of AMRZ traded up $1.81 during mid-day trading on Wednesday, reaching $48.94. The company had a trading volume of 4,190,061 shares, compared to its average volume of 3,790,697. The stock's 50-day moving average is $50.90. Amrize has a 52 week low of $44.12 and a 52 week high of $56.29. The company has a quick ratio of 0.85, a current ratio of 1.38 and a debt-to-equity ratio of 0.42.

Amrize (NYSE:AMRZ - Get Free Report) last released its earnings results on Wednesday, August 6th. The company reported $0.78 EPS for the quarter, missing analysts' consensus estimates of $1.03 by ($0.25).

Insider Activity

In other news, insider Jaime Hill bought 4,000 shares of the firm's stock in a transaction that occurred on Friday, August 8th. The shares were bought at an average cost of $46.40 per share, for a total transaction of $185,600.00. Following the completion of the transaction, the insider owned 9,601 shares of the company's stock, valued at approximately $445,486.40. This represents a 71.42% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CFO Ian A. Johnston purchased 10,500 shares of the business's stock in a transaction on Friday, August 8th. The shares were purchased at an average price of $47.71 per share, with a total value of $500,955.00. Following the acquisition, the chief financial officer directly owned 17,344 shares in the company, valued at $827,482.24. This represents a 153.42% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased 1,124,000 shares of company stock valued at $53,225,260 in the last quarter.

Institutional Investors Weigh In On Amrize

Several large investors have recently bought and sold shares of AMRZ. BNP Paribas Financial Markets purchased a new position in shares of Amrize in the 2nd quarter worth $59,000. Groupe la Francaise purchased a new stake in Amrize during the second quarter valued at approximately $60,000. Allianz SE purchased a new position in shares of Amrize in the 2nd quarter worth approximately $80,000. Osaic Holdings Inc. purchased a new stake in Amrize during the 2nd quarter valued at $90,000. Finally, Credit Industriel ET Commercial bought a new stake in Amrize in the second quarter worth $109,000.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.